相关实验视频
Updated: Jul 23, 2025

07:06
Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
33.2K
肌酸作为抗药物的潜在作用:临床前研究的证据
Eman A Alraddadi1,2, Abdulrahman M Khojah1,3, Faisal F Alamri1,2
1Department of Basic Sciences, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Frontiers in neuroscience
|July 17, 2023
概括
肌酸补充剂通过解决大脑能量代谢和线粒体功能障碍,显示出管理的潜在抗性质. 需要进一步的临床试验来确认作为附加或单一疗法的疗效.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 线粒体生物学 线粒体生物学
背景情况:
- 是一种常见的神经系统疾病,对公共健康有重大影响.
- 目前的治疗方法对许多患者无效,需要新的治疗标.
- 大脑能量代谢受损和线粒体功能障碍越来越多地与病原发生有关.
研究的目的:
- 审查肌酸补充剂在神经疾病中的潜在应用.
- 探索肌酸在准大脑能量中的作用,特别是在中.
- 讨论肌酸作为治疗的治疗剂的潜力.
主要方法:
- 关于动物和人类研究的文献综述.
- 对肌酸作为能量缓冲器和穿器的特性进行分析.
- 对克reatine抗作用的临床前证据的检查.
主要成果:
- 有限的临床前证据表明,肌酸具有抗性质.
- 肌酸在的作用机制需要进一步阐明.
- 线粒体功能障碍是的关键病理组成部分.
结论:
- 肌酸通过准大脑的能量,显示出对管理的希望.
- 需要进一步的研究,包括更大的临床试验.
- 肌酸可以作为的有效补充或单一疗法.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Antiepileptic Drugs: Glutamate Antagonists
427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
349
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
349
Antiepileptic Drugs: Calcium Channel Blockers
465
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
465
Arteries of the Lower Limbs
215
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215

